| Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients (NCT00502502) | M.D. Anderson Cancer Center | 2002-11-01 |
| A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis (NCT00149201) | Japan Clinical Oncology Group | 2002-11-01 |
| Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer (NCT00113581) | Merck KGaA, Darmstadt, Germany | 2002-10-01 |
| Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus (NCT00048529) | Tularik | 2002-09-01 |
| T900607 in Treating Patients With Gastroesophageal Junction Cancer (NCT00054249) | University Hospitals Seidman Cancer Center | 2002-09-01 |
| Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer (NCT00040859) | Alliance for Clinical Trials in Oncology | 2002-09-01 |
| Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer (NCT00033657) | Eastern Cooperative Oncology Group | 2002-08-15 |
| Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer (NCT00963092) | Cancer Research UK | 2002-08-01 |
| Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors (NCT00178698) | The University of Texas Health Science Center, Houston | 2002-07-01 |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract (NCT00012246) | The University of Texas Medical Branch, Galveston | 2002-07-01 |
| Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer (NCT00032123) | SWOG Cancer Research Network | 2002-06-01 |
| Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients (NCT00899626) | Vanderbilt University Medical Center | 2002-06-01 |
| Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer (NCT00195572) | Wyeth is now a wholly owned subsidiary of Pfizer | 2002-05-01 |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (NCT00310115) | M.D. Anderson Cancer Center | 2002-04-01 |
| Evaluation of Double Tract Reconstruction After Total Gastrectomy in Patients With Gastric Cancer (NCT00746161) | Wakayama Medical University | 2002-04-01 |
| Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer (NCT00150670) | Taiho Pharmaceutical Co., Ltd. | 2002-03-01 |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction (NCT00022139) | Alliance for Clinical Trials in Oncology | 2002-01-01 |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer (NCT00027534) | Michael Morse, MD | 2002-01-01 |
| Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) (NCT00152217) | Taiho Pharmaceutical Co., Ltd. | 2001-09-01 |
| Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer (NCT00165464) | Dana-Farber Cancer Institute | 2001-08-01 |
| Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor (NCT00021047) | National Institutes of Health Clinical Center (CC) | 2001-07-01 |
| Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer (NCT00020787) | Jonsson Comprehensive Cancer Center | 2001-07-01 |
| S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer (NCT00023634) | SWOG Cancer Research Network | 2001-06-01 |
| The Impact of Immunostimulating Nutrition on the Outcome of Surgery (NCT00558155) | Jagiellonian University | 2001-06-01 |
| Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery (NCT00011960) | Radiation Therapy Oncology Group | 2001-05-01 |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer (NCT00025532) | University of California, San Francisco | 2001-04-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer (NCT00010270) | University Hospital Freiburg | 2001-04-01 |
| Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach (NCT00009880) | Radiation Therapy Oncology Group | 2001-04-01 |
| Assessing Quality of Life of Patients With Stomach Cancer (NCT00020826) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-04-01 |
| Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer (NCT00477880) | Vanderbilt University | 2001-04-01 |
| Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach (NCT00075465) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2001-04-01 |
| DX-8951f in Treating Patients With Metastatic Stomach Cancer (NCT00017212) | Daiichi Sankyo | 2001-04-01 |
| S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus (NCT00012363) | SWOG Cancer Research Network | 2001-04-01 |
| Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults (NCT00613665) | Novartis Vaccines | 2001-02-01 |
| S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach (NCT00004233) | SWOG Cancer Research Network | 2001-02-01 |
| Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients (NCT02518529) | Cancer Advances Inc. | 2001-02-01 |
| BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy (NCT00017043) | Bristol-Myers Squibb | 2001-02-01 |
| BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy (NCT00017056) | Memorial Sloan Kettering Cancer Center | 2001-02-01 |
| Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers (NCT00183846) | University of Southern California | 2000-12-01 |
| A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer (NCT00142350) | Japan Clinical Oncology Group | 2000-11-01 |
| Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma (NCT00215514) | Dana-Farber Cancer Institute | 2000-09-01 |
| Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer (NCT00588263) | Memorial Sloan Kettering Cancer Center | 2000-07-01 |
| Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma (NCT00215462) | Dana-Farber Cancer Institute | 2000-06-01 |
| Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer (NCT00006081) | M.D. Anderson Cancer Center | 2000-06-01 |
| Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin (NCT00166881) | National Taiwan University Hospital | 2000-06-01 |
| Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer (NCT00209638) | Hokkaido Gastrointestinal Cancer Study Group | 2000-05-01 |
| Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach (NCT00020761) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery (NCT00005876) | Astex Pharmaceuticals, Inc. | 2000-04-01 |
| Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer (NCT00017537) | University of Alabama at Birmingham | 2000-03-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors (NCT00014456) | Dartmouth-Hitchcock Medical Center | 2000-03-01 |
| Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract (NCT00582647) | Memorial Sloan Kettering Cancer Center | 2000-03-01 |
| Biological Therapy in Treating Patients With Advanced Cancer (NCT00005956) | Duke University | 2000-02-01 |
| Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus (NCT00005607) | Robert H. Lurie Cancer Center | 2000-02-01 |
| Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer (NCT00006038) | Memorial Sloan Kettering Cancer Center | 2000-02-01 |
| Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer (NCT00005599) | Memorial Sloan Kettering Cancer Center | 2000-02-01 |
| Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach (NCT00004127) | University of Chicago | 2000-02-01 |
| Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer (NCT02450032) | Cancer Advances Inc. | 2000-02-01 |
| Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach (NCT00004235) | Alliance for Clinical Trials in Oncology | 2000-01-01 |
| Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction (NCT00004911) | Northwestern University | 2000-01-01 |
| Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction (NCT00004910) | Northwestern University | 2000-01-01 |
| Cytokine Gene Polymorphisms in Gastric Diseases (NCT00197470) | Hamamatsu University | 2000-01-01 |
| Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer (NCT00005060) | Swiss Cancer Institute | 1999-11-01 |
| Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer (NCT00003862) | Radiation Therapy Oncology Group | 1999-11-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer (NCT00005638) | Memorial Sloan Kettering Cancer Center | 1999-10-01 |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery (NCT00004895) | Northwestern University | 1999-10-01 |
| Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan (NCT00183859) | University of Southern California | 1999-09-01 |
| Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer (NCT00004873) | Swiss Cancer Institute | 1999-08-01 |
| Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer. (NCT02233712) | Cancer Advances Inc. | 1999-08-01 |
| Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer (NCT00004065) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer (NCT00004099) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-07-01 |
| Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer (NCT00003298) | ECOG-ACRIN Cancer Research Group | 1999-06-01 |
| Nutrition Intervention Trials in Linxian Follow-up Study (NCT00342654) | National Cancer Institute (NCI) | 1999-05-20 |
| Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder (NCT00489515) | Wake Forest University Health Sciences | 1999-02-01 |
| Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer (NCT02521649) | Cancer Advances Inc. | 1998-09-01 |
| Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer (NCT00004236) | University of Leicester | 1998-08-01 |
| Irinotecan in Treating Patients With Esophageal or Stomach Cancer (NCT00003748) | Jonsson Comprehensive Cancer Center | 1998-08-01 |
| Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer (NCT00004103) | NYU Langone Health | 1998-07-01 |
| Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach (NCT00003237) | Eastern Cooperative Oncology Group | 1998-06-22 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors (NCT00019435) | National Cancer Institute (NCI) | 1998-05-01 |
| Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer (NCT00003427) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer (NCT00019474) | Montefiore Medical Center | 1998-03-01 |
| Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus (NCT00003192) | University of Chicago | 1998-03-01 |
| Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach (NCT00003157) | Alliance for Clinical Trials in Oncology | 1998-02-01 |
| Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors (NCT00003125) | Georgetown University | 1998-01-01 |
| Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer (NCT00003172) | Eastern Cooperative Oncology Group | 1997-12-01 |
| Irinotecan in Treating Patients With Advanced Cancer of the Stomach (NCT00003137) | Alliance for Clinical Trials in Oncology | 1997-12-01 |
| Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer (NCT00544193) | City of Hope Medical Center | 1997-12-01 |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen (NCT00003046) | M.D. Anderson Cancer Center | 1997-08-01 |
| A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC) (NCT00152243) | Taiho Pharmaceutical Co., Ltd. | 1997-06-01 |
| Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer (NCT00003055) | Memorial Sloan Kettering Cancer Center | 1997-06-01 |
| Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer (NCT00005049) | NYU Langone Health | 1997-05-01 |
| Biological Therapy in Treating Patients With Metastatic Cancer (NCT00004604) | Duke University | 1997-02-01 |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus (NCT00002883) | UNICANCER | 1996-10-01 |
| Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer (NCT00002783) | Memorial Sloan Kettering Cancer Center | 1996-05-01 |
| Extended Resection After Positive Intraoperative Pathology in Gastric Cancer Surgery (NCT05663450) | University Hospital of Cologne | 1996-05-01 |
| Multivisceral Resections for Locally Advanced Gastric Cancer (NCT06103435) | Jagiellonian University | 1996-01-01 |
| High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer (NCT00002722) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-01-01 |
| Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach (NCT00003617) | Lymphoma Trials Office | 1995-03-01 |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer (NCT00002615) | Medical Research Council | 1994-06-01 |
| Phase III Study OF the Gastric Surgery on Advanced Stage Gastric Cancer (NCT00260884) | National Health Research Institutes, Taiwan | 1993-10-01 |